Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.19 | N/A |
| PEG Ratio (TTM) | 2.31 | N/A |
| P/S Ratio (TTM) | 1.17 | N/A |
| P/B Ratio (TTM) | 1.68 | N/A |
| P/FCF Ratio (TTM) | 13.51 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.77 | N/A |
| Price to 5YR AVG FCF Ratio | 12.21 | N/A |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.75% | N/A |
| ROE (TTM) | 21.37% | N/A |
| Net Profit Margin (TTM) | 14.49% | N/A |
| ROIC 5YR AVG | 16.96% | N/A |
Growth (93%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 16.03% | 48.06% | 35.78% |
| Revenue | 7.13% | 13.02% | 8.97% |
| Net Income | 14.88% | 38.89% | 27.57% |
| Cash Flow | 81.13% | 45.11% | 28.69% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 19.62 | N/A |
| Quick Ratio (TTM) | 3.62 | N/A |
| D/E Ratio (TTM) | 0.37 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 4.53 | N/A |
| LTL to 5YR AVG FCF | 2.73 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.47% | N/A |